Program
Travoprost
Also written as “Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)”, “Travoprost 0.004% / Timolol maleate 0.5%” and “Travoprost 0.004% ophthalmic solution”.
Its studies are mostly in Glaucoma, Open-Angle · Glaucoma · Glaucoma, Angle-Closure · Low Tension Glaucoma · Hydrophthalmos, led by 5 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Alcon | 520 open or running | phase 4since May 28, 2003 | Jan 3, 2003 | none ahead |
| Glaukos | 72 open or running | phase 4since Sep 28, 2011 | Sep 28, 2011 | none ahead |
| Ocular Therapeutix | 20 open or running | phase 3since Sep 21, 2016 | Dec 4, 2014 | none ahead |
| Laboratorios Sophia S.A de C.V. | 10 open or running | phase 1since May 23, 2019 | May 23, 2019 | none ahead |
| Viatris | 10 open or running | phase 4since Feb 16, 2009 | Feb 16, 2009 | none ahead |
Also a collaborator on its studies: ppd-development-lp.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 46 studies since May 28, 2003.
- Jul 26, 2012Phase 3 study in HydrophthalmosAlcon · NCT01652664 · 184 enrolled
- Aug 3, 2012Phase 1 study in GlaucomaAlcon · NCT01658839 · 25 enrolled
- Aug 10, 2012Phase 4 study in GlaucomaAlcon · NCT01664039 · 104 enrolled
- Sep 27, 2012Phase 4 study in GlaucomaAlcon · NCT01696383
- Nov 21, 2013Phase 4 study in Low Tension GlaucomaAlcon · NCT01995136 · 32 enrolled · Japan
- Dec 2, 2013Phase 4 study in Glaucoma, Open-AngleAlcon · NCT02003391 · 157 enrolled
- Dec 4, 2014Ocular Therapeutix's first study: phase 2 study in GlaucomaNew to Ocular TherapeutixOcular Therapeutix · NCT02312544 · 72 enrolled · United States
- Aug 11, 2016Phase 4 study in Glaucoma, Open-AngleGlaukos · NCT02873806 · 53 enrolled · Armenia
- Sep 21, 2016Phase 3 study in Glaucoma, Open-AngleOcular Therapeutix · NCT02914509 · 565 enrolled · United States
- May 23, 2019Laboratorios Sophia S.A de C.V.'s first study: phase 1 study in GlaucomaNew to Laboratorios Sophia S.A de C.V.Laboratorios Sophia S.A de C.V. · NCT03965052 · 24 enrolled · Mexico
- Oct 29, 2020Phase 2 study in Glaucoma, Open-AngleGlaukos · NCT04615403 · 33 enrolled · United States, Philippines
- Sep 25, 2023Phase 3 study in Glaucoma, Open-AngleGlaukos · NCT06061718 · 60 enrolled · Armenia
- Aug 30, 2024Phase 2 study in Glaucoma, Open-AngleGlaukos · NCT06582732 · 210 enrolled · Armenia
- Feb 1, 2025Phase 4 study in Glaucoma, Open-AngleGlaukos · NCT06848946 · 132 planned · United States
TargetBeta
“Prostanoid FP receptor agonist”ChEMBL 37, by rule
Other programs on PTGFR
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| AGN-193408 | AbbVie | phase 2 | 1 |
Studies
The newest 60 of 63 led by companies developing it. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT06848946Glaucoma, Open-Angle · United States | 4 | Recruiting | Glaukos | Aug 2026 | 132 |
| NCT06582732Glaucoma, Open-Angle · Armenia | 2 | Completed | Glaukos | Nov 2, 2023 | 210 |
| NCT06061718Glaucoma, Open-Angle · Armenia | 3 | Active, not recruiting | Glaukos | Mar 18, 2024 | 60 |
| NCT04615403Glaucoma, Open-Angle · United States, Philippines | 2 | Completed | Glaukos | Feb 28, 2022 | 33 |
| NCT03965052Glaucoma · Mexico | 1 | Completed | Laboratorios Sophia S.A de C.V. | Jul 2, 2019 | 24 |
| NCT02914509Glaucoma, Open-Angle · United States | 3 | Completed | Ocular Therapeutix | Mar 30, 2019 | 565 |
| NCT02873806Glaucoma, Open-Angle · Armenia | 4 | Completed | Glaukos | Nov 8, 2019 | 53 |
| NCT02312544Glaucoma · United States | 2 | Completed | Ocular Therapeutix | Sep 2015 | 72 |
| NCT02003391Glaucoma, Open-Angle | 4 | Completed | Alcon | May 2015 | 157 |
| NCT01995136Low Tension Glaucoma · Japan | 4 | Completed | Alcon | Jun 2014 | 32 |
| NCT01696383Glaucoma | 4 | Withdrawn | Alcon | Feb 2013 | 0 |
| NCT01664039Glaucoma | 4 | Completed | Alcon | Jun 2014 | 104 |
| NCT01658839Glaucoma | 1 | Completed | Alcon | Jul 2013 | 25 |
| NCT01652664Hydrophthalmos | 3 | Completed | Alcon | Mar 2014 | 184 |
| NCT01510145Glaucoma, Open-Angle | 4 | Completed | Alcon | May 2013 | 191 |
| NCT01510132Glaucoma, Open-Angle | 4 | Withdrawn | Alcon | Jan 2012 | 0 |
| NCT01493427Glaucoma, Open-Angle | 4 | Completed | Alcon | Feb 2013 | 202 |
| NCT01464424Glaucoma | 4 | Completed | Alcon | Jun 2012 | 84 |
| NCT01453855Glaucoma, Open-Angle | 3 | Completed | Alcon | Aug 2012 | 1,099 |
| NCT01452009Glaucoma, Open-Angle | 3 | Withdrawn | Alcon | Dec 2011 | 0 |
| NCT01444040Glaucoma, Open-Angle · Armenia | 4 | Completed | Glaukos | Mar 28, 2019 | 196 |
| NCT01443988Glaucoma, Open-Angle · Armenia | 4 | Completed | Glaukos | Jan 2017 | 101 |
| NCT01336569Glaucoma · United States | 4 | Completed | Alcon | Mar 2012 | 50 |
| NCT01327599Glaucoma, Open-Angle | 4 | Completed | Alcon | Nov 2012 | 60 |
| NCT01298687Glaucoma, Open-Angle | 2 | Completed | Alcon | Apr 2011 | 67 |
| NCT01230736Glaucoma · Germany | 4 | Completed | Alcon | Feb 2011 | 105 |
| NCT01114893Glaucoma, Open-Angle · United States | 2 | Completed | Alcon | May 2010 | 60 |
| NCT00966940Glaucoma | 4 | Completed | Alcon | Mar 2010 | 51 |
| NCT00928590Glaucoma, Open-Angle | 3 | Completed | Alcon | Nov 2010 | 155 |
| NCT00872651Glaucoma, Open-Angle · China | 3 | Completed | Alcon | Nov 2011 | 242 |
| NCT00848536Glaucoma, Open-Angle | 3 | Completed | Alcon | Jan 2010 | 371 |
| NCT00847483Glaucoma · United States | 4 | Completed | Viatris | Aug 2002 | 375 |
| NCT00798759Glaucoma, Open-Angle | 4 | Completed | Alcon | May 2009 | 236 |
| NCT00767494Glaucoma · Belgium | 3 | Terminated | Alcon | Feb 2009 | 17 |
| NCT00767481Glaucoma · Mexico | 3 | Terminated | Alcon | Feb 2009 | 6 |
| NCT00763061Glaucoma · United States | 4 | Completed | Alcon | Apr 2008 | 111 |
| NCT00761319Glaucoma, Open-Angle | 3 | Completed | Alcon | Sep 2009 | 705 |
| NCT00762645Glaucoma, Angle-Closure | 4 | Completed | Alcon | May 2008 | 30 |
| NCT00760539Glaucoma, Open-Angle · Japan | 3 | Completed | Alcon | Dec 2008 | 87 |
| NCT00759239Glaucoma, Open-Angle · United Kingdom | 4 | Completed | Alcon | Jan 2011 | 36 |
| NCT00758342Intraocular Pressure | 4 | Terminated | Alcon | Mar 2008 | 37 |
| NCT00708422Glaucoma | 4 | Completed | Alcon | Aug 2009 | 231 |
| NCT00690794Glaucoma, Open-Angle | 3 | Completed | Alcon | May 2009 | 726 |
| NCT00672997Glaucoma, Open-Angle | 3 | Completed | Alcon | Dec 2008 | 301 |
| NCT00670033Ocular Hypertension | 2 | Completed | Alcon | Sep 2008 | 158 |
| NCT00527592Glaucoma, Open-Angle | 4 | Completed | Alcon | Aug 2008 | 54 |
| NCT00527501Glaucoma, Open-Angle · United States | 2 | Completed | Alcon | Dec 2007 | 136 |
| NCT00519753Glaucoma · Germany | 4 | Completed | Alcon | Dec 2008 | 522 |
| NCT00508469Glaucoma, Open-Angle · Spain | 4 | Completed | Alcon | Jan 2010 | 102 |
| NCT00471380Glaucoma · Italy | 4 | Completed | Alcon | Oct 2008 | 46 |
| NCT00471068Glaucoma, Open-Angle · Portugal | 4 | Terminated | Alcon | Aug 2008 | 46 |
| NCT00468988Glaucoma · United States | 4 | Completed | Alcon | Jul 2007 | 30 |
| NCT00465803Glaucoma, Open-Angle · United States | 3 | Completed | Alcon | Jan 2009 | 81 |
| NCT00444665Glaucoma · United States | 4 | Completed | Alcon | Aug 2007 | 750 |
| NCT00333125Glaucoma | 3 | Completed | Alcon | Feb 2007 | 319 |
| NCT00311389Glaucoma, Open-Angle · Belgium | 3 | Completed | Alcon | Sep 2004 | 408 |
| NCT00293800Glaucoma, Open-Angle | 3 | Completed | Alcon | Dec 2005 | 173 |
| NCT00293787Glaucoma, Open-Angle | 3 | Completed | Alcon | Aug 2005 | 156 |
| NCT00288951Glaucoma, Open-Angle | 3 | Completed | Alcon | Jun 2005 | 690 |
| NCT00061503Glaucoma · United States | 4 | Completed | Alcon | Mar 2004 |
How it is read
Names in the registry
- “Travoprost”, 6 entries
- “Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)”, 5 entries
- “Travoprost 0.004% / Timolol maleate 0.5%”, 2 entries
- “Travoprost 0.004% ophthalmic solution”, 2 entries
- “Travoprost ophthalmic solution, 0.004%”, 2 entries
Conditions, from the studies’ own filings
- Glaucoma, Open-Angle, 42 studies
- Glaucoma, 20 studies
- Glaucoma, Angle-Closure, 2 studies
- Low Tension Glaucoma, 1 study
- Hydrophthalmos, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.